Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

READER REQUEST: "How Are You Seeing GILD, Gilead Sciences, After They Posted Weaker Than Expected Earnings?"

|Includes: Gilead Sciences, Inc. (GILD)

Last night we recommended REGN (Regeneron) as a shortsale. Today we are adding both GILD (Gilead) and IBB (ETF Biotech) to that shortsale list.

We read that the biotechs are coming back. I just don't see it. Predatory pricing that abuses the sick have driven massive sales gain -- but greed based on exploiting the sick (and jacking up insurance premiums) is a devil's game that is going to have to end, with some blood no doubt.

GILD was punished today after-hours when earnings fell short of expectations. In the monthly charts, GILD has been a shortsell for some time now. IBB, also a short in the monthly charts.

Happy hunting.


Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.